← Back to Warburg Pincus profile
Warburg Pincus related stories
All articles and analysis
- VCs Take Loss on Prestwick Pharma Sale
Biovail Corp. (NYSE: BVF) has acquired Prestwick Pharmaceuticals Inc., a Washington, D.C.-based drug company focused on CNS disorders, for $100 million in cash. Prestwick had raised around $120 million in total VC funding since 2002, from firms like Atlas Venture, Pequot Ventures, Scale Venture Partners, Sofinnova Ventures, Vivo Ventures and Warburg Pincus.
- PE Week Wire: Thursday, September 18, 2008
Random Ramblings
- PE Week Wire: Thursday, September 18, 2008
Random Ramblings
- PE Week Wire: Tuesday, September 16, 2008
Random Ramblings
- PE Week Wire: Tuesday, September 16, 2008
Random Ramblings
- Done deals, week of Sept. 15, 2008
Deals are disclosed transactions from Sept. 3 to Sept. 10, based on Thomson Reuters data